Belgium - Healthcare, Regulatory and Reimbursement Landscape

Belgium - Healthcare, Regulatory and Reimbursement Landscape

  • March 2021 •
  • 150 pages •
  • Report ID: 6033468 •
  • Format: PDF
Belgium - Healthcare, Regulatory and Reimbursement Landscape

The analyst has released its latest report: “Belgium - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of healthcare, regulatory, and reimbursement landscape in Belgium.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The Belgium pharmaceutical market was worth $7.90 in 2013, which increased to $8.00B in 2019 at a CAGR of 3.1%. The market value is expected to increase further to $8.10B by 2025. Belgium is a well-developed healthcare market in Western Europe with universal health coverage. Government initiatives such as eHealth 2019-2021 and Artificial Intelligence for Belgium (AI4Belgium) are intended to encourage the adoption of digital health solutions. Belgium’s healthcare infrastructure, aging population, innovation-focused R&D investments in pharmaceutical companies, and increased prevalence of chronic diseases are attributed to the growth of the pharmaceutical market.

- The report provides information on the healthcare, regulatory, and reimbursement landscape in Belgium, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sanofi, AstraZeneca, and UCB
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Zimmer Biomet, Agfa-Gevaert NV, and IBA
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Belgium healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Belgium’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Belgium’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

We are very sorry, but an error occurred.
Please contact if the problem remains.